378 related articles for article (PubMed ID: 10098447)
21. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment.
Ricotti R; Seregni M; Ciardo D; Vigorito S; Rondi E; Piperno G; Ferrari A; Zerella MA; Arculeo S; Francia CM; Sibio D; Cattani F; De Marinis F; Spaggiari L; Orecchia R; Riboldi M; Baroni G; Jereczek-Fossa BA
Med Phys; 2018 Apr; 45(4):1360-1368. PubMed ID: 29431863
[TBL] [Abstract][Full Text] [Related]
23. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer.
Eminowicz G; Rompokos V; Stacey C; Hall L; McCormack M
Radiother Oncol; 2017 Jan; 122(1):116-121. PubMed ID: 27863962
[TBL] [Abstract][Full Text] [Related]
24. Potential benefits of dosimetric VMAT tracking verified with 3D film measurements.
Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2016 May; 43(5):2162. PubMed ID: 27147328
[TBL] [Abstract][Full Text] [Related]
25. Assessment of robustness of institutional applied clinical target volume (CTV) to planning target volume (PTV) margin in cervical cancer using biological models.
Savanović M; Štrbac B
Med Dosim; 2021 Spring; 46(1):51-56. PubMed ID: 32873469
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors.
Balter JM; Brock KK; Lam KL; Tatro D; Dawson LA; McShan DL; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):610-4. PubMed ID: 16095848
[TBL] [Abstract][Full Text] [Related]
27. A strategy to objectively evaluate the necessity of correcting detected target deviations in image guided radiotherapy.
Yue NJ; Kim S; Jabbour S; Narra V; Haffty BG
Med Phys; 2007 Nov; 34(11):4340-7. PubMed ID: 18072499
[TBL] [Abstract][Full Text] [Related]
28. A new method of incorporating systematic uncertainties in intensity-modulated radiotherapy optimization.
Yang J; Mageras GS; Spirou SV; Jackson A; Yorke E; Ling CC; Chui CS
Med Phys; 2005 Aug; 32(8):2567-79. PubMed ID: 16193787
[TBL] [Abstract][Full Text] [Related]
29. Isotoxic dose escalation in the treatment of lung cancer by means of heterogeneous dose distributions in the presence of respiratory motion.
Baker M; Nielsen M; Hansen O; Jahn JW; Korreman S; Brink C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):849-55. PubMed ID: 21570211
[TBL] [Abstract][Full Text] [Related]
30. Coverage-based treatment planning: optimizing the IMRT PTV to meet a CTV coverage criterion.
Gordon JJ; Siebers JV
Med Phys; 2009 Mar; 36(3):961-73. PubMed ID: 19378757
[TBL] [Abstract][Full Text] [Related]
31. Internal organ motion in prostate cancer patients treated in prone and supine treatment position.
Stroom JC; Koper PC; Korevaar GA; van Os M; Janssen M; de Boer HC; Levendag PC; Heijmen BJ
Radiother Oncol; 1999 Jun; 51(3):237-48. PubMed ID: 10435819
[TBL] [Abstract][Full Text] [Related]
32. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
Admiraal MA; Schuring D; Hurkmans CW
Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
[TBL] [Abstract][Full Text] [Related]
33. Pelvic Organ Motion during Radiotherapy for Cervical Cancer: Understanding Patterns and Recommended Patient Preparation.
Eminowicz G; Motlib J; Khan S; Perna C; McCormack M
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e85-91. PubMed ID: 27178706
[TBL] [Abstract][Full Text] [Related]
34. Treatment plan evaluation using dose-volume histogram (DVH) and spatial dose-volume histogram (zDVH).
Cheng CW; Das IJ
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1143-50. PubMed ID: 10192366
[TBL] [Abstract][Full Text] [Related]
35. Set-Up Errors, Organ Motion, Tumour Regression and its Implications on Internal Target Volume-Planning Target Volume During Cervical Cancer Radiotherapy: Results From a Prospective Study.
Mahantshetty U; Naga P; Nachankar A; Ghadi Y; Dheera A; Scaria L; Epili D; Chopra S; Lavanya G; Shrivastava S
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):189-197. PubMed ID: 34736842
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of clinical margins via simulation of patient setup errors in prostate IMRT treatment plans.
Gordon JJ; Crimaldi AJ; Hagan M; Moore J; Siebers JV
Med Phys; 2007 Jan; 34(1):202-14. PubMed ID: 17278506
[TBL] [Abstract][Full Text] [Related]
37. Optimized planning target volume for intact cervical cancer.
Khan A; Jensen LG; Sun S; Song WY; Yashar CM; Mundt AJ; Zhang FQ; Jiang SB; Mell LK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1500-5. PubMed ID: 22270167
[TBL] [Abstract][Full Text] [Related]
38. A method of calculating a lung clinical target volume DVH for IMRT with intrafractional motion.
Kung JH; Zygmanski P; Choi N; Chen GT
Med Phys; 2003 Jun; 30(6):1103-9. PubMed ID: 12852534
[TBL] [Abstract][Full Text] [Related]
39. CT-guided intensity-modulated radiotherapy for bladder cancer: isocentre shifts, margins and their impact on target dose.
Redpath AT; Muren LP
Radiother Oncol; 2006 Dec; 81(3):276-83. PubMed ID: 17113669
[TBL] [Abstract][Full Text] [Related]
40. Practical robustness evaluation in radiotherapy - A photon and proton-proof alternative to PTV-based plan evaluation.
Korevaar EW; Habraken SJM; Scandurra D; Kierkels RGJ; Unipan M; Eenink MGC; Steenbakkers RJHM; Peeters SG; Zindler JD; Hoogeman M; Langendijk JA
Radiother Oncol; 2019 Dec; 141():267-274. PubMed ID: 31492443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
